BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12506438)

  • 1. Prescription drug formularies: ensuring access to safe and effective medications.
    Weiss H
    Healthplan; 2002; 43(6):52-4. PubMed ID: 12506438
    [No Abstract]   [Full Text] [Related]  

  • 2. Perspectives. Options vs. limits: drug cost strategies reconsidered.
    Cunningham R
    Faulkner Grays Med Health; 1997 Sep; 51(38):suppl 4. PubMed ID: 10173171
    [No Abstract]   [Full Text] [Related]  

  • 3. Point/counterpoint. The HMO pharmacy benefit. In-house pharmacy administration: the benefits of integration.
    Penna P
    HMO; 1995; 36(4):56, 58-9. PubMed ID: 10166487
    [No Abstract]   [Full Text] [Related]  

  • 4. As drug costs rise, health plans shift the burden.
    Capitation Manag Rep; 1997 Oct; 4(10):153-8. PubMed ID: 10175783
    [No Abstract]   [Full Text] [Related]  

  • 5. HMOs try formularies in effort to curb prescription costs.
    Feldman A
    Contract Healthc; 1988 Jul; ():33-5. PubMed ID: 10290628
    [No Abstract]   [Full Text] [Related]  

  • 6. Managed care outlook. Formularies get stricter.
    Manag Care; 1997 Aug; 6(8):130. PubMed ID: 10170242
    [No Abstract]   [Full Text] [Related]  

  • 7. Will pharmacy costs overwhelm medical networks?
    Med Netw Strategy Rep; 1998 Aug; 7(8):1, 6-9. PubMed ID: 10182869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formularies tighten and physicians adapt.
    Lawrence J
    Manag Care; 1998 Mar; 7(3):23-6, 29-30. PubMed ID: 10177957
    [No Abstract]   [Full Text] [Related]  

  • 9. The future of managed care drug formularies.
    Navarro RP
    Med Interface; 1994 Apr; 7(4):62-4. PubMed ID: 10133359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Data watch. Is this the way to manage pharmacy costs?
    Bus Health; 1997 Sep; 15(9):94. PubMed ID: 10173238
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug wars. Health plans blast Calif. regulators for requiring them to retain medications on their formularies.
    Rauber C
    Mod Healthc; 1999 May; 29(19):74. PubMed ID: 10387863
    [No Abstract]   [Full Text] [Related]  

  • 12. Getting serious about generics.
    Sipkoff M
    Manag Care; 2003 Jan; 12(1):36-9. PubMed ID: 12575509
    [No Abstract]   [Full Text] [Related]  

  • 13. Point/counterpoint. The HMO pharmacy benefit. Contracted pharmacy services: the value of a carve-out PBM.
    Reissman D
    HMO; 1995; 36(4):57, 60-1. PubMed ID: 10166488
    [No Abstract]   [Full Text] [Related]  

  • 14. Choosing the right PBM.
    Brodsky KL
    HMO; 1995; 36(3):107-9, 112. PubMed ID: 10166470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulas for success or cause for concern?
    Kaldy J
    Contemp Longterm Care; 1997 Mar; 20(3):56. PubMed ID: 10165681
    [No Abstract]   [Full Text] [Related]  

  • 16. Formularies and state regulation.
    Jackson RA
    Healthplan; 1996; 37(6):19-20, 23. PubMed ID: 10162983
    [No Abstract]   [Full Text] [Related]  

  • 17. Patient power: getting the drug you need.
    Spragins EE
    Newsweek; 1999 Apr; 133(17):78. PubMed ID: 10351752
    [No Abstract]   [Full Text] [Related]  

  • 18. Substitutions and rebates: questionable materiel management practices in HMOs?
    Summers J
    J Healthc Mater Manage; 1993 Aug; 11(7):54-5. PubMed ID: 10131843
    [No Abstract]   [Full Text] [Related]  

  • 19. Increasing stakes and complex dynamics in the formulary process.
    Tadlock C
    Manag Care Interface; 2007 Mar; 20(3):12, 14. PubMed ID: 17458473
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluating the role and services offered by PBMs.
    Exec Solut Healthc Manag; 2000 Mar; 3(3):2-4. PubMed ID: 10977729
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.